V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250008254 | 250005654 | 1.59 | 97.7 | Palliative (P) | 2013-08-16 | 2013-08-16 | Carboplatin + Etoposide iv&po | 02 | N | 250030226 | TRIAL |
| 250008255 | 250005655 | 1.58 | 52.2 | Disease modification (D) | 2014-02-07 | 2014-02-07 | Trial Unspecified | 1 | N | 250030364 | PEMETREXED |
| 250008256 | 250005656 | 1.68 | null | Disease modification (D) | null | 2018-01-22 | IPM | null | null | 250030471 | CARBOPLATIN |
| 250008257 | 250005657 | 1.72 | 60.8 | Palliative (P) | 2016-01-26 | 2016-02-05 | Cytarabine Low Dose | 2 | null | 250030629 | TRIAL |
| 250008258 | 250005657 | null | null | null | 2019-04-29 | 2019-04-29 | Imatinib 400mg | 1 | N | 250030629 | PEMETREXED |
| 250008259 | 250005658 | 1.66 | 69.8 | Palliative (P) | 2017-09-08 | 2017-09-28 | Azacitidine | N | N | 250031215 | FEC |
| 250008260 | 250005659 | 1.65 | null | Curative (C) | 2016-01-31 | 2016-01-31 | CISPLATIN + RT | N | N | 250031350 | CISPLATIN |
| 250008261 | 250005659 | null | null | Not known (9) | 2013-06-03 | 2013-06-03 | Gemcitabine 1000mg/m2 D1 8 15 | 01 | N | 250031350 | CYTARABINE |
| 250008262 | 250005659 | 1.67 | 74 | Palliative (P) | 2016-06-02 | 2016-06-07 | Docetaxel | N | null | 250031350 | GEMCITABINE + PACLITAXEL |
| 250008263 | 250005660 | 0 | 39.5 | Disease modification (D) | 2018-06-03 | 2018-06-03 | Cytarabine Low Dose | N | N | 250031791 | TRIAL |
| 250008264 | 250005661 | null | 76.3 | null | 2015-04-24 | 2015-04-24 | BCG Intravesical | 02 | N | 250031884 | CARBOPLATIN + ETOPOSIDE |
| 250008265 | 250005662 | 1.5 | 74.5 | Not known (9) | 2016-06-04 | 2016-06-05 | Trial Unspecified | 01 | N | 250032031 | NILOTINIB |
| 250008266 | 250005663 | 1.75 | null | Disease modification (D) | null | 2017-02-28 | GemCarbo Days 1+8 | N | null | 250032320 | CISPLATIN + GEMCITABINE |
| 250008267 | 250005663 | 1.82 | 0 | Curative (C) | 2019-02-06 | 2019-02-06 | Capecitabine | N | N | 250032320 | CARBOPLATIN |
| 250008268 | 250005663 | 0 | 63.95 | Curative (C) | 2017-05-08 | 2017-05-08 | Enzalutamide | 02 | N | 250032320 | TRIAL |
| 250008269 | 250005663 | 1.65 | null | Palliative (P) | 2016-03-18 | 2016-04-29 | IPM | N | N | 250032320 | CARBOPLATIN |
| 250008270 | 250012900 | 0 | 79.8 | Curative (C) | 2017-01-12 | 2017-01-12 | Carboplatin + Paclitaxel (3 weekly) | 2 | N | 250032815 | TRIAL |
| 250008271 | 250012900 | null | null | null | 2017-02-20 | 2017-02-20 | MESO-02 TRIAL | 02 | N | 250032815 | PEMETREXED |
| 250008272 | 250012900 | 0 | 87.5 | Disease modification (D) | 2016-10-08 | 2016-11-05 | Trial Unspecified | 02 | N | 250032815 | CARBOPLATIN |
| 250008273 | 250012900 | 0 | 0 | null | 2016-07-18 | 2016-07-18 | Cisplatin + Vinorelbine (PO) | N | N | 250032815 | AZACITIDINE |
| 250008274 | 250005664 | null | null | Palliative (P) | 2017-11-28 | 2017-12-07 | SCOT TRIAL | 1 | Y | 250001748 | BUSULPHAN |
| 250008275 | 250005665 | 1.5 | 69.4 | Palliative (P) | 2019-01-29 | 2019-01-29 | Pemetrexed | 99 | Y | 250002113 | CISPLATIN |
| 250008276 | 250009960 | 1.62 | null | Disease modification (D) | null | 2019-02-13 | CARBOPLATIN | null | null | 250004070 | TRIAL |
| 250008277 | 250005666 | 1.83 | 15 | Disease modification (D) | 2016-07-26 | 2016-08-04 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 250005733 | TRIAL |
| 250008278 | 250005667 | null | 110.9 | Curative (C) | 2016-08-24 | 2016-08-29 | Trial Unspecified | 01 | N | 250005783 | TRIAL |
| 250008279 | 250005667 | 1.58 | 71.2 | Palliative (P) | 2016-01-25 | 2016-01-25 | Docetaxel 75mg/m2 (21 day) | N | N | 250005783 | TRIAL |
| 250008280 | 250011703 | 0 | 61 | Disease modification (D) | 2018-09-20 | 2018-09-20 | CISPLATIN + GEMCITABINE | 02 | N | 250007776 | PEMETREXED |
| 250008281 | 250005668 | 1.68 | null | null | 2016-11-29 | 2016-12-17 | Trial Unspecified | null | N | 250008338 | TRIAL |
| 250008282 | 250009962 | 1.54 | null | Palliative (P) | 2019-06-01 | 2019-06-01 | MESO-02 TRIAL | 2 | N | 250008341 | PEMETREXED |
| 250008283 | 250011704 | 1.8 | 59.5 | Disease modification (D) | 2018-06-29 | 2018-06-29 | MESO-02 TRIAL | 02 | N | 250008865 | NOT MATCHED |
| 250008284 | 250011704 | 0 | 88.9 | Palliative (P) | 2019-03-29 | 2019-04-03 | IPM | N | N | 250008865 | TRIAL |
| 250008285 | 250005669 | null | 74.3 | Curative (C) | 2017-11-29 | 2017-11-29 | Trial Unspecified | N | null | 250009542 | TRIAL |
| 250008286 | 250009963 | 1.87 | 72 | Curative (C) | 2017-09-20 | 2017-09-25 | EOX | N | N | 250009904 | VINORELBINE |
| 250008287 | 250009963 | null | 91 | Adjuvant (A) | 2019-03-18 | 2019-03-20 | CHOP R | Y | N | 250009904 | TEMOZOLOMIDE |
| 250008288 | 250009963 | 1.62 | 100 | Curative (C) | 2017-05-06 | 2017-05-06 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 250009904 | GEMCITABINE |
| 250008289 | 250009963 | 1.63 | 60 | Palliative (P) | 2018-09-12 | 2018-09-12 | Bevacizumab + CISPLATIN + PEMETREXED | N | N | 250009904 | GEMCITABINE + PACLITAXEL |
| 250008290 | 250009963 | 1.91 | null | Palliative (P) | 2016-03-02 | 2016-03-10 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 250009904 | TRIAL |
| 250008291 | 250009963 | 1.63 | 0 | Disease modification (D) | 2015-04-02 | 2015-04-07 | Cytarabine Low Dose | 02 | N | 250009904 | TEMOZOLOMIDE |
| 250008292 | 250012922 | null | null | Palliative (P) | 2016-09-15 | 2016-10-03 | Pemetrexed | N | N | 250013214 | RUXOLITINIB |
| 250008293 | 250012929 | 1.8 | 75.2 | Palliative (P) | null | 2019-02-13 | AML18 PILOT TRIAL | N | N | 250013351 | TRIAL |
| 250008294 | 250012929 | 1.7 | 0 | Disease modification (D) | 2017-05-18 | 2018-12-03 | Cisplatin + Docetaxel | N | N | 250013351 | MELPHALAN |
| 250008295 | 250012929 | null | null | null | null | 2018-10-27 | RUXOLITINIB | 99 | N | 250013351 | GEMCARBO |
| 250008296 | 250012929 | 1.68 | 100.2 | Palliative (P) | 2017-12-18 | 2017-12-18 | EC | N | N | 250013351 | CARBOPLATIN |
| 250008297 | 250005670 | 1.69 | null | Palliative (P) | 2018-01-01 | 2018-01-01 | Gemcitabine 1000mg/m2 D1 8 15 | 2 | N | 250015099 | CARBOPLATIN |
| 250008298 | 250005670 | 1.85 | 75.2 | Palliative (P) | 2015-06-21 | 2015-06-21 | FLUOROURACIL + MITOMYCIN | N | N | 250015099 | TRIAL |
| 250008299 | 250005670 | 1.5 | 101.8 | Palliative (P) | 2017-10-02 | 2017-10-02 | Azacitidine | N | N | 250015099 | NOT MATCHED |
| 250008300 | 250005670 | 1.56 | 71.9 | Palliative (P) | 2014-08-16 | 2014-08-16 | Trial Unspecified | N | N | 250015099 | TRIAL |
| 250008301 | 250012729 | null | 57.35 | Palliative (P) | 2018-08-17 | 2018-08-17 | CARBOPLATIN | 02 | N | 250019740 | PEMETREXED |
| 250008302 | 250005671 | null | 74.1 | Palliative (P) | 2019-04-30 | 2019-04-30 | Trial Unspecified | 1 | N | 250021765 | VINORELBINE |
| 250008303 | 250005671 | 1.54 | null | Disease modification (D) | 2018-06-02 | 2018-06-02 | Pemetrexed | 2 | N | 250021765 | PEMETREXED |